FMR Adds $235M in Baxter International Inc. ($BAX)

Key Points

  • FMR changed its Baxter International Inc. ($BAX) stake by 32.9% last quarter, boosting to 46,264,804 shares worth $947.97 million.
  • Wall Street's consensus rating on $BAX is Hold and an average price target of $21.54.
  • $BAX last traded around $20.49.

FMR increased its position in Baxter International Inc. ($BAX) by 32.9% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 46,264,804 shares of Baxter International Inc. after buying 11,453,034 shares during the quarter. FMR's holdings in Baxter International Inc. were worth $947.97 million as of its most recent filing.

Baxter International Inc. ($BAX) Stock

Last price$20.49
Market cap$10.77B
Forward P/E10.36
PEG ratio36.68
Beta0.64
52-week low$15.73
52-week high$31.76
50-day MA$18.21
200-day MA$19.77
Current ratio1.85
Quick ratio1.02
Debt-to-equity1.61

Baxter International Inc. Earnings

EPS (ttm)$-1.91
Revenue (ttm)$11.32B
Revenue growth2.9%
Net margin-9.7%
Return on equity-15.0%
Next earningsApr 30, 2026

Baxter International Inc. Dividend

Annual dividend$0.20
Dividend yield96.00%
Payout ratio307.7%
Ex-dividend dateMay 29, 2026

Analysts Set New Price Targets

ConsensusHold
Average target$21.54
High target$40.00
Low target$17.00
Analysts covering12

About Baxter International Inc.

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors' offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.

ExchangeNYSE
SectorHealthcare
IndustryMedical Instruments & Supplies
HeadquartersDeerfield, IL
CEOMr. Andrew P. Hider
Employees37,500

See Also

This instant news alert was generated by automated narrative technology and financial data from Opentrades and public regulatory filings. It is for informational purposes only and is not financial advice.